← Open Payments lookup

SHEILA HATTON: Open Payments

NPI 1215554803 · SOUTHGATE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,648 in 162 payments from 17 companies in 2025. Trend: 2023 $2,212 · 2024 $2,882 · 2025 $2,648

Food & beverage: $2,641Education: $8
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$374
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$343
Vanda Pharmaceuticals Inc.12$301
Alkermes, Inc.17$261
ABBVIE INC.22$244
Collegium Pharmaceutical, Inc.11$200
Supernus Pharmaceuticals, Inc.17$159
Axsome Therapeutics, Inc.7$150
Corium, LLC9$140
Takeda Pharmaceuticals U.S.A., Inc.6$98

Products named: CAPLYTA, ABILIFY MAINTENA, VRAYLAR, ARISTADA, HETLIOZ, Jornay PM, REXULTI, Qelbree.

Industry payments across MI — which companies pay providers there.